KLOW Protocol – 80mg

The KLOW Protocol is a quad peptide blend combining GHK-Cu, BPC-157, TB-500, and KPV into a single 80mg lyophilized vial, delivering the same four compound regenerative and anti inflammatory peptide combination as the F40 Biotech KLOW Pen 145mg in a reconstitute vial format. iLab Pharma’s lyophilized vial presentation provides precise dosing flexibility and reconstitution control for researchers who prefer the adjustability of a vial based preparation over the fixed dose convenience of a prefilled pen system.

The four compound mechanism of the KLOW Protocol addresses tissue repair and inflammation modulation across four distinct but synergistic biological pathways simultaneously. GHK-Cu (Copper Tripeptide 1) drives extracellular matrix remodeling through metalloproteinase modulation and collagen and elastin synthesis stimulation, Addressing the structural tissue rebuilding phase of repair. BPC-157 promotes angiogenesis through nitric oxide pathway modulation and activates the FAK paxillin pathway driving cell migration and wound healing, providing the vascular development and growth factor signaling foundation for tissue repair. TB-500 (Thymosin Beta 4) upregulates actin polymerization and cell motility pathways, enhancing cellular migration to injury sites and supporting new blood vessel formation through a complementary angiogenic mechanism that pairs synergistically with BPC-157’s nitric oxide pathway activity. KPV: a tripeptide fragment from the C terminal sequence of alpha melanocyte stimulating hormone, contributes direct NF κB inhibition and melanocortin receptor mediated anti inflammatory activity, targeting the inflammatory component of tissue injury that the other three compounds approach primarily through structural and vascular mechanisms.

The KLOW Protocol lyophilized vial format and the F40 Biotech KLOW Pen serve the same four compound research profile across different administration format preferences; the vial offering reconstitution flexibility and precise concentration adjustment, the pen offering ready to use fixed dose convenience. CSD stocking both formats from different manufacturers gives researchers the ability to select based on protocol administration requirements while maintaining the same compound combination and research profile. Individual components are also available separately across multiple formats and concentrations throughout CSD’s full peptide range for researchers requiring custom dosing ratios or single compound sourcing.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across all four components before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s KLOW Protocol meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched in tissue repair, anti inflammatory, and regenerative biology research contexts. Browse CSD’s full peptide range for complete sourcing.